While the specific mechanisms vary, many interventions exert their therapeutic effects by modulating key signaling pathways associated with migraine, including the NF-κB pathway (57), Nrf2 antioxidant pathway (58, 65), and ERK/CREB/BDNF pathway (62). This evidence concerns the gene BDNF and migraine disorder.